Pediatrics Doctors in Lewiston, ID Accepting Medicare

8 Pediatrics doctors found. Showing 1 - 8

Natale Carasali, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2315 8th St, Lewiston, ID 83501 Phone: 208-746-1383    Fax: 208-746-6348

Gregory P Schultz, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2315 8th St, Lewiston, ID 83501 Phone: 208-746-1383    Fax: 208-746-6348

Dr. Darby S Lynch, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2315 8th St, Lewiston, ID 83501 Phone: 208-746-1383    Fax: 208-746-6348

Theodore K Krisher, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 2315 8th St, Lewiston, ID 83501 Phone: 208-746-1383    Fax: 208-746-6348

Robert Todd Parkey, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2315 8th St, Lewiston, ID 83501 Phone: 208-746-1383    Fax: 208-746-6348

Dr. Craig N. Ambroson, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2315 8th St, Lewiston, ID 83501 Phone: 208-746-1383    Fax: 208-746-6348

Dr. Tysen L Weber, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2315 8th St, Lewiston, ID 83501 Phone: 208-746-1383    Fax: 208-746-6348

Dr. Angela Ruth Roth, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 2315 8th St, Lewiston, ID 83501 Phone: 208-746-1383    Fax: 208-746-1383

News Archive

FDA grants EarlySense marketing clearance for EverOn Touch system

EarlySense announced today that its EverOn Touch system has been cleared for marketing by the U.S. Food and Drug Administration. The FDA clearance covers several key additions to the traditional EverOn contact-free patient supervision system value proposition. For the first time, the EverOn system includes an online display that alerts medical staff regarding a patient's motion level and verifies patient turns as indicated by nurses. Identifying low patient movement and then turning patients methodically are key elements in the prevention of pressure ulcers, the most costly patient safety risk in U.S. hospitals.

FDA approves first drug for patients with hypereosinophilic syndrome in nearly 14 years

Today, the U.S. Food and Drug Administration approved Nucala (mepolizumab) for adults and children aged 12 years and older with hypereosinophilic syndrome (HES) for six months or longer without another identifiable non-blood related cause of the disease.

Current alcohol use rate for blacks aged 18 and older significantly lower than national adult average: Study

The current alcohol use rate for blacks aged 18 and older is significantly lower than the national adult average (44.3 percent versus 55.2 percent) according to a new study based on a national survey.

Using smart phones to manage HIV treatment in rural Virginia

An innovative plan developed at the University of Virginia School of Medicine will use smart phones to improve care for people recently diagnosed with HIV in rural Virginia.

Omeros to present results from first pivotal Phase 3 trial of OMS302 at AAO annual meeting

Omeros Corporation today reported that it will present data from its first pivotal Phase 3 clinical trial evaluating OMS302 at the American Academy of Ophthalmology (AAO) Annual Meeting, which will take place from November 10 through November 13 in Chicago, Illinois.

Read more Medical News

› Verified 4 days ago